These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1425972)

  • 41. Contractile 5-HT1 receptors in human isolated pial arterioles: correlation with 5-HT1D binding sites.
    Hamel E; Bouchard D
    Br J Pharmacol; 1991 Jan; 102(1):227-33. PubMed ID: 2043924
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of the serotonin receptors that mediate smooth muscle contraction in canine and porcine coronary artery.
    Cushing DJ; Cohen ML
    J Pharmacol Exp Ther; 1992 Jun; 261(3):856-62. PubMed ID: 1602389
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of 5-HT receptors on human pulmonary artery and vein: functional and binding studies.
    Cortijo J; Martí-Cabrera M; Bernabeu E; Domènech T; Bou J; Fernández AG; Beleta J; Palacios JM; Morcillo EJ
    Br J Pharmacol; 1997 Dec; 122(7):1455-63. PubMed ID: 9421295
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serotonin receptors in rat jugular vein: presence and involvement in the contraction.
    Linder AE; Gaskell GL; Szasz T; Thompson JM; Watts SW
    J Pharmacol Exp Ther; 2010 Jul; 334(1):116-23. PubMed ID: 20378714
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery.
    Hamel E; Robert JP; Young AR; MacKenzie ET
    J Pharmacol Exp Ther; 1989 Jun; 249(3):879-89. PubMed ID: 2732950
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanisms of 5-hydroxytryptamine-induced contraction of isolated rat intrapulmonary bronchi.
    Szarek JL; Zhang JZ; Gruetter CA
    Pulm Pharmacol; 1995 Dec; 8(6):273-81. PubMed ID: 8819182
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 5-Hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats.
    MacLean MR; Sweeney G; Baird M; McCulloch KM; Houslay M; Morecroft I
    Br J Pharmacol; 1996 Nov; 119(5):917-30. PubMed ID: 8922741
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of 5-hydroxytryptamine on neurogenic vasoconstriction in the isolated, autoperfused hindquarters of the rat.
    Calama E; Ortíz de Urbina AV; Morán A; Martín ML; San Román L
    Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):894-900. PubMed ID: 16173953
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 2-(2-Aminoethyl)-quinoline (D-1997): a novel agonist at 5-hydroxytryptamine1-like receptors in the canine basilar artery.
    Terrón JA; López-Muñoz FJ; Hong E; Villalón CM
    Arch Int Pharmacodyn Ther; 1994; 327(1):56-68. PubMed ID: 7944828
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of maturation, artery size, and chronic hypoxia on 5-HT receptor type in ovine cranial arteries.
    Teng GQ; Williams J; Zhang L; Purdy R; Pearce WJ
    Am J Physiol; 1998 Sep; 275(3):R742-53. PubMed ID: 9728071
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serotonin-induced contraction in porcine coronary artery: use of ergolines to support vascular 5-hydroxytryptamine2-receptor heterogeneity.
    Cushing DJ; Cohen ML
    J Pharmacol Exp Ther; 1993 Jan; 264(1):193-200. PubMed ID: 8423526
    [TBL] [Abstract][Full Text] [Related]  

  • 52. GR127935 is a potent antagonist of the 5-HT1-like receptor mediating contraction in the canine coronary artery.
    Terrón JA
    Eur J Pharmacol; 1996 Apr; 300(1-2):109-12. PubMed ID: 8741174
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sumatriptan-induced saphenous venoconstriction in the anaesthetized dog through 5-HT1-like receptor activation.
    Drieu la Rochelle C; O'Connor SE
    Br J Pharmacol; 1995 Oct; 116(4):2207-12. PubMed ID: 8564250
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence that 5-HT2 receptors predominantly mediate the contraction of the rat basilar artery to 5-hydroxytryptamine.
    Deckert V; Angus JA
    Eur J Pharmacol; 1992 Oct; 221(1):17-25. PubMed ID: 1459189
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of the contractile serotonergic receptor in guinea pig trachea with agonists and antagonists.
    Watts SW; Cohen ML
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1101-6. PubMed ID: 1312158
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 5-HT receptors mediating contractions of the isolated human coronary artery.
    Bax WA; Renzenbrink GJ; Van Heuven-Nolsen D; Thijssen EJ; Bos E; Saxena PR
    Eur J Pharmacol; 1993 Aug; 239(1-3):203-10. PubMed ID: 7693489
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.
    Kemp BK; Cocks TM
    Br J Pharmacol; 1995 Oct; 116(4):2183-90. PubMed ID: 8564247
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of oxyhemoglobin on vasoconstriction in response to 5-hydroxytryptamine in isolated, perfused canine basilar arteries.
    Orz YI; Tsuji T; Aoki T; Yen Y; Chiba S; Kobayashi S
    Neurosurgery; 1998 Nov; 43(5):1176-84. PubMed ID: 9802861
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evidence that spinal 5-HT1, 5-HT2 and 5-HT3 receptor subtypes modulate responses to noxious colorectal distension in the rat.
    Danzebrink RM; Gebhart GF
    Brain Res; 1991 Jan; 538(1):64-75. PubMed ID: 2018933
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of the 5-hydroxytryptamine receptor which mediates contraction of the human isolated basilar artery.
    Parsons AA; Whalley ET
    Cephalalgia; 1989; 9 Suppl 9():47-51. PubMed ID: 2544283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.